ClinConnect ClinConnect Logo
Search / Trial NCT06941922

Testicular Evaluation of Azoospermia Using Micro-Ultrasound

Launched by PAUL SHIN · Apr 16, 2025

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Azoospermia, Infertility, Microultrasound, Microdissection

ClinConnect Summary

This clinical trial, titled "Testicular Evaluation of Azoospermia Using Micro-Ultrasound," is investigating a condition called azoospermia, which means that a man has no sperm in his semen. The study will use a special imaging technique called micro-ultrasound to look closely at the seminiferous tubules in the testes, which are the structures responsible for producing sperm. The goal is to gather information that could help shape future research in this area.

To be eligible for this study, participants must be men over 18 who have been diagnosed with azoospermia through semen analysis. This includes men who have had a vasectomy and confirmed azoospermia afterward, as well as those who have shown natural fertility before a vasectomy. However, men who have previously had surgery on their testes or have certain hormonal conditions will not be able to participate. While the study is not yet recruiting participants, those who take part can expect to undergo micro-ultrasound imaging to help researchers understand more about this condition.

Gender

MALE

Eligibility criteria

  • Inclusion criteria:
  • 1. Men with azoospermia confirmed based on semen analysis
  • 2. Post-vasectomy patients with verified azoospermia after the procedure
  • 3. Men pre-vasectomy with proven natural fertility or with normal semen analysis
  • 4. Males assigned at birth over the age of 18
  • Exclusion criteria:
  • 1. History of prior microdissection of the testes
  • 2. History of hypogonadotropic hypogonadism

About Paul Shin

Paul Shin is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, he leads projects that span various therapeutic areas, emphasizing rigorous methodology and ethical standards. Paul Shin collaborates with a network of experienced researchers and healthcare professionals to ensure the successful design, implementation, and management of clinical trials. His proactive approach and strategic vision aim to accelerate the development of effective treatments while prioritizing participant safety and regulatory compliance.

Locations

Edmonton, Alberta, Canada

Rockville, Maryland, United States

Patients applied

KD

1 patients applied

Trial Officials

Paul R Shin, MD

Principal Investigator

Shady Grove Fertility

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported